Term	Overlap	P.value	Adjusted.P.value	Old.P.value	Old.Adjusted.P.value	Odds.Ratio	Combined.Score	Genes
Protein processing in endoplasmic reticulum	49/171	3.11894839818845e-23	8.51472912705446e-21	0	0	7.53864635601393	390.667439306535	TRAM1;HERPUD1;SEC61A1;SEC61G;MAN1A1;SEC61B;SIL1;SEC13;SSR4;SSR3;MOGS;PDIA6;CKAP4;PDIA4;ERN1;DNAJC1;SELENOS;PREB;RPN2;SAR1B;DERL3;RPN1;SEL1L;DERL1;RRBP1;HSP90B1;UBE2J1;ERLEC1;LMAN1;LMAN2;UGGT2;TXNDC5;XBP1;SEC24A;HSPA5;HSPA1L;WFS1;EDEM1;EDEM2;HSPA6;EIF2AK3;SYVN1;EIF2AK4;STT3A;HYOU1;P4HB;SEC24D;HSPA1B;HSPA1A
Protein export	9/23	1.24602201702771e-06	0.000170082005324282	0	0	11.6700451992878	158.660735146136	SEC61A1;SPCS3;SPCS2;SPCS1;HSPA5;SEC61G;SRPRB;SEC61B;SEC11C
N-Glycan biosynthesis	12/50	7.98177462241949e-06	0.000726341490640173	0	0	5.7419028340081	67.4004639112197	B4GALT2;B4GALT3;ST6GAL1;RPN2;ALG5;RPN1;ALG14;MGAT3;STT3A;MAN1A1;MOGS;ALG1
Various types of N-glycan biosynthesis	8/39	0.000816688480831442	0.0557389888167459	0	0	4.67605981955259	33.2479675756422	B4GALT2;B4GALT3;RPN2;RPN1;ALG14;STT3A;MAN1A1;ALG1
Vibrio cholerae infection	8/50	0.00427891647411186	0.233628839486508	0	0	3.44937055281883	18.813058303005	SEC61A1;KDELR1;SEC61G;PLCG2;KDELR2;SEC61B;KDELR3;PDIA4
Glycosaminoglycan biosynthesis	7/53	0.0203705966528183	0.882056645303652	0	0	2.75252756396921	10.7174140673255	B4GALT2;B4GALT3;CHPF;CHPF2;CHST15;B4GALT7;CHST2
Small cell lung cancer	10/92	0.022616837059068	0.882056645303652	0	0	2.20799588034268	8.36623029997562	LAMA5;CCNE2;CCNE1;GADD45A;MYC;COL4A4;COL4A3;ITGA6;LAMC1;FHIT
Mannose type O-glycan biosynthesis	4/23	0.0303006896972238	0.999995617189958	0	0	3.80253113700281	13.2958725920588	B4GALT2;B4GALT3;B4GAT1;LARGE1
Aldosterone-regulated sodium reabsorption	5/37	0.0430494803133637	0.999995617189958	0	0	2.82294651384909	8.8793104178087	PRKCG;IRS1;INSR;SCNN1B;IGF1
Glycine, serine and threonine metabolism	5/40	0.0572218770480322	0.999995617189958	0	0	2.58057033701733	7.38254461960391	SHMT2;PSAT1;CTH;PHGDH;GCAT
Glyoxylate and dicarboxylate metabolism	4/30	0.0704112578391056	0.999995617189958	0	0	2.77774515560775	7.37047487391914	MCEE;SHMT2;HYI;ACSS1
Glutathione metabolism	6/57	0.0779734605167281	0.999995617189958	0	0	2.12540771566753	5.42273710530534	GSTM2;GPX7;CHAC2;CHAC1;GSTT2B;SRM
Breast cancer	12/147	0.0870617633789758	0.999995617189958	0	0	1.60794871794872	3.92522389466148	DLL4;FZD3;JUN;WNT10A;WNT5B;GADD45A;MYC;HEY2;LRP5;IGF1;ESR1;ESR2
Longevity regulating pathway	9/102	0.0883346690874057	0.999995617189958	0	0	1.7494510252683	4.24525743055798	HSPA1L;IRS1;INSR;CREB3L2;HSPA6;EHMT1;IGF1;HSPA1B;HSPA1A
ECM-receptor interaction	8/88	0.0914322445962853	0.999995617189958	0	0	1.80727969348659	4.32329690928789	LAMA5;COL4A4;COL4A3;ITGA8;SDC1;ITGA6;COL9A3;LAMC1
Thyroid hormone synthesis	7/75	0.0989593963302861	0.999995617189958	0	0	1.85983675766957	4.30188732400001	PRKCG;HSPA5;CREB3L2;GPX7;TSHR;PDIA4;HSP90B1
Fluid shear stress and atherosclerosis	11/139	0.115457100011544	0.999995617189958	0	0	1.55364433237272	3.35409477176416	MEF2C;GSTM2;JUN;CAV2;CAV1;PECAM1;SDC1;GSTT2B;ASS1;KLF2;HSP90B1
Measles	11/139	0.115457100011544	0.999995617189958	0	0	1.55364433237272	3.35409477176416	IFNAR2;JUN;CCNE2;HSPA1L;CCNE1;HSPA6;EIF2AK3;TLR9;EIF2AK4;HSPA1B;HSPA1A
Toxoplasmosis	9/112	0.135406409646172	0.999995617189958	0	0	1.57876364854927	3.15669778472273	LAMA5;HSPA1L;HSPA6;LY96;ITGA6;LAMC1;HLA-DOB;HSPA1B;HSPA1A
Pathways in cancer	34/531	0.137124114352479	0.999995617189958	0	0	1.23992283761508	2.4635640241413	LAMA5;LRP5;IL5RA;LAMC1;HSP90B1;RASGRP3;DLL4;BCL2L11;MYC;GNG7;HEY2;PLCG2;PIM2;GSTT2B;PRKCG;IFNAR2;FZD3;GSTM2;JUN;WNT10A;WNT5B;GADD45A;DCC;PTCH2;IGF1;ESR1;ESR2;CCNE2;CCNE1;COL4A4;COL4A3;MDM2;GNB3;ITGA6
Focal adhesion	14/201	0.1740602482425	0.999995617189958	0	0	1.35314724944103	2.36578011580785	PRKCG;LAMA5;JUN;CAV2;CAV1;IGF1;LAMC1;MYL2;COL4A4;COL4A3;ITGA8;PIP5K1B;COL9A3;ITGA6
Legionellosis	5/57	0.179531111217193	0.999995617189958	0	0	1.73536110498861	2.98032090060622	HSPA1L;SAR1B;HSPA6;HSPA1B;HSPA1A
Estrogen signaling pathway	10/137	0.18505720864078	0.999995617189958	0	0	1.42223464869195	2.3994382315077	JUN;HSPA1L;CREB3L2;HSPA6;ESR1;EBAG9;ESR2;HSPA1B;HSP90B1;HSPA1A
p53 signaling pathway	6/73	0.185241299809698	0.999995617189958	0	0	1.61647784024429	2.72553678900133	TP53I3;CCNE2;CCNE1;GADD45A;MDM2;IGF1
Pertussis	6/76	0.209850020781889	0.999995617189958	0	0	1.54695438404807	2.41535608517105	C4B;C4A;JUN;C1R;CFL2;LY96
Glycosphingolipid biosynthesis	4/45	0.210592706992564	0.999995617189958	0	0	1.7601005399367	2.74193620886257	B4GALT2;B4GALT3;SLC33A1;ST6GALNAC4
Antigen processing and presentation	6/78	0.226858257434391	0.999995617189958	0	0	1.5038240917782	2.23081758165916	HSPA1L;HSPA5;HSPA6;HLA-DOB;HSPA1B;HSPA1A
Other types of O-glycan biosynthesis	4/47	0.23321617562149	0.999995617189958	0	0	1.67805787324694	2.44289897048389	B4GALT2;B4GALT3;C1GALT1C1;ST6GAL1
Basal cell carcinoma	5/63	0.236225333639596	0.999995617189958	0	0	1.55534696834964	2.2443176554434	FZD3;WNT10A;WNT5B;GADD45A;PTCH2
Amino sugar and nucleotide sugar metabolism	4/48	0.244741748724289	0.999995617189958	0	0	1.63983344899375	2.3081503772425	GMPPB;GMPPA;PGM3;NANS
Intestinal immune network for IgA production	4/48	0.244741748724289	0.999995617189958	0	0	1.63983344899375	2.3081503772425	CCL25;TNFRSF17;HLA-DOB;CCR10
Fructose and mannose metabolism	3/33	0.250187755915477	0.999995617189958	0	0	1.80343183984747	2.49873347860649	GMPPB;GMPPA;KHK
Cell adhesion molecules	10/148	0.25244730080559	0.999995617189958	0	0	1.30810314612368	1.80067299842484	CLDN3;CADM1;CLDN14;ICAM2;ITGA8;PECAM1;SDC1;ITGA6;HLA-DOB;MPZL1
B cell receptor signaling pathway	6/81	0.253150298233707	0.999995617189958	0	0	1.44344168260038	1.98295962641913	CD79B;CD79A;JUN;BLNK;PLCG2;RASGRP3
Propanoate metabolism	3/34	0.26458936095612	0.999995617189958	0	0	1.74516436544789	2.32032906845158	MCEE;EHHADH;ACSS1
Arginine and proline metabolism	4/50	0.268146030329297	0.999995617189958	0	0	1.56837039495519	2.06432606085283	PYCR1;PYCR3;ALDH18A1;SRM
Cysteine and methionine metabolism	4/50	0.268146030329297	0.999995617189958	0	0	1.56837039495519	2.06432606085283	PSAT1;CTH;PHGDH;SRM
Hepatocellular carcinoma	11/168	0.270504014458842	0.999995617189958	0	0	1.2647136205388	1.65357301792357	PRKCG;FZD3;GSTM2;WNT10A;WNT5B;GADD45A;MYC;PLCG2;GAB1;LRP5;GSTT2B
Vitamin B6 metabolism	1/6	0.276926453568184	0.999995617189958	0	0	3.60475737392959	4.62852043099291	PSAT1
Nicotinate and nicotinamide metabolism	3/35	0.279087125570438	0.999995617189958	0	0	1.69053860819828	2.15751823133957	NADK2;QPRT;CD38
Proteoglycans in cancer	13/205	0.28349857407812	0.999995617189958	0	0	1.22226900866218	1.54072898110328	PRKCG;FZD3;WNT10A;WNT5B;CAV2;CAV1;GAB1;IGF1;ESR1;MYC;PLCG2;MDM2;SDC1
One carbon pool by folate	2/20	0.283799853733338	0.999995617189958	0	0	2.0031746031746	2.52297042763354	SHMT2;ALDH1L2
Mitophagy	5/68	0.286709783032436	0.999995617189958	0	0	1.431527720926	1.78838579931989	JUN;PINK1;CITED2;UBC;EIF2AK3
Alanine, aspartate and glutamate metabolism	3/37	0.30827059245164	0.999995617189958	0	0	1.5909269332137	1.87216675630349	GPT2;ASNS;ASS1
Arginine biosynthesis	2/22	0.323360760030842	0.999995617189958	0	0	1.80266666666667	2.03518664597576	GPT2;ASS1
Regulation of lipolysis in adipocytes	4/55	0.328047844041372	0.999995617189958	0	0	1.4142343960485	1.5762997396262	IRS1;INSR;MGLL;TSHR
Glioma	5/75	0.360034999200927	0.999995617189958	0	0	1.28789739391459	1.31565677588411	PRKCG;GADD45A;PLCG2;MDM2;IGF1
Vitamin digestion and absorption	2/24	0.362339317808212	0.999995617189958	0	0	1.63861471861472	1.66347932737525	TCN2;MMACHC
Wnt signaling pathway	10/166	0.376096259257395	0.999995617189958	0	0	1.15606082976524	1.13052363065123	PRKCG;FZD3;JUN;WNT10A;TLE1;WNT5B;MYC;CBY1;LRP5;CSNK1E
Gastric cancer	9/149	0.383995985772309	0.999995617189958	0	0	1.15923846048487	1.10953400187117	FZD3;WNT10A;WNT5B;CCNE2;CCNE1;GADD45A;MYC;GAB1;LRP5
FoxO signaling pathway	8/131	0.384423722299437	0.999995617189958	0	0	1.17278758994486	1.12119653632557	BCL2L11;IRS1;GADD45A;INSR;MDM2;CSNK1E;IGF1;KLF2
Leukocyte transendothelial migration	7/114	0.393035771205191	0.999995617189958	0	0	1.17951079908778	1.10149164489763	PRKCG;CLDN3;CLDN14;MYL2;PLCG2;PECAM1;RAPGEF3
Fatty acid degradation	3/43	0.395718807479859	0.999995617189958	0	0	1.35185891325072	1.25324270093929	ACADVL;ECI1;EHHADH
Folate biosynthesis	2/26	0.400439866384431	0.999995617189958	0	0	1.50190476190476	1.37453072738296	MOCOS;GGH
Prostate cancer	6/97	0.402434862132011	0.999995617189958	0	0	1.18864118672914	1.0819273920628	CCNE2;CCNE1;CREB3L2;MDM2;IGF1;HSP90B1
PI3K-Akt signaling pathway	20/354	0.403514860478003	0.999995617189958	0	0	1.08004920391775	0.980189974669317	IFNAR2;LAMA5;IRS1;INSR;IGF1;LAMC1;HSP90B1;BCL2L11;CCNE2;CCNE1;MYC;COL4A4;GNG7;CREB3L2;COL4A3;MDM2;ITGA8;GNB3;COL9A3;ITGA6
mTOR signaling pathway	9/154	0.421838638774773	0.999995617189958	0	0	1.11896717029788	0.965816831127108	PRKCG;FZD3;WNT10A;SEC13;WNT5B;IRS1;INSR;LRP5;IGF1
GnRH secretion	4/64	0.436547844877872	0.999995617189958	0	0	1.20152671755725	0.995894190332322	PRKCG;KISS1R;KCNN3;ESR2
Amoebiasis	6/102	0.449679418726308	0.999995617189958	0	0	1.12643403441683	0.900269006536363	PRKCG;LAMA5;COL4A4;COL4A3;HSPB1;LAMC1
Endocytosis	14/252	0.455871149361646	0.999995617189958	0	0	1.0602969511504	0.832911049696145	SH3GLB2;HSPA1L;CAV2;CAV1;HSPA6;ARFGAP1;ACAP3;AGAP5;PIP5KL1;CHMP4C;MDM2;PIP5K1B;HSPA1B;HSPA1A
Complement and coagulation cascades	5/85	0.464968228381306	0.999995617189958	0	0	1.12631327602674	0.862515165675094	C4B;C4A;C1R;CD59;CFB
ErbB signaling pathway	5/85	0.464968228381306	0.999995617189958	0	0	1.12631327602674	0.862515165675094	PRKCG;JUN;MYC;GAB1;PLCG2
Colorectal cancer	5/86	0.47523632326028	0.999995617189958	0	0	1.11234921645619	0.827524497696224	JUN;BCL2L11;DCC;GADD45A;MYC
Circadian rhythm	2/31	0.490482269737228	0.999995617189958	0	0	1.24262725779967	0.885205592982341	BHLHE41;CSNK1E
Malaria	3/50	0.493501235531936	0.999995617189958	0	0	1.15009228647344	0.812229579444493	PECAM1;TLR9;SDC1
Epstein-Barr virus infection	11/202	0.497125161867479	0.999995617189958	0	0	1.03770035859599	0.725262737533935	IFNAR2;JUN;BCL2L11;CCNE2;GADD45A;CCNE1;MYC;PLCG2;MDM2;BLNK;HLA-DOB
Ovarian steroidogenesis	3/51	0.506845335860847	0.999995617189958	0	0	1.12607244995234	0.765221834529191	INSR;IGF1;BMP6
SNARE interactions in vesicular transport	2/33	0.524051627364122	0.999995617189958	0	0	1.16233486943164	0.751060196931126	BET1L;BET1
Non-small cell lung cancer	4/72	0.528540047884265	0.999995617189958	0	0	1.05972159856309	0.675717383063733	PRKCG;GADD45A;PLCG2;FHIT
Endocrine and other factor-regulated calcium reabsorption	3/53	0.532968894746813	0.999995617189958	0	0	1.08091515729266	0.680211493930769	PRKCG;KLK1;ESR1
Staphylococcus aureus infection	5/95	0.564126602831931	0.999995617189958	0	0	1.00063673989175	0.572841098243442	C4B;C4A;C1R;HLA-DOB;CFB
Mucin type O-glycan biosynthesis	2/36	0.571534870286912	0.999995617189958	0	0	1.05960784313725	0.592776184939142	C1GALT1C1;ST6GALNAC4
Lipid and atherosclerosis	11/215	0.581352782942822	0.999995617189958	0	0	0.970899022433181	0.52661320916497	ERN1;JUN;XBP1;HSPA1L;HSPA5;HSPA6;EIF2AK3;LY96;HSPA1B;HSPA1A;HSP90B1
Apelin signaling pathway	7/137	0.585846252683125	0.999995617189958	0	0	0.969642988590357	0.518466061278596	BORCS8-MEF2B;MEF2C;MEF2B;MYL2;GNG7;GNB3;KLF2
African trypanosomiasis	2/37	0.586578532967136	0.999995617189958	0	0	1.02927891156463	0.549067516662335	PRKCG;TLR9
Thyroid cancer	2/37	0.586578532967136	0.999995617189958	0	0	1.02927891156463	0.549067516662335	GADD45A;MYC
Growth hormone synthesis, secretion and action	6/119	0.600829551082152	0.999995617189958	0	0	0.956107548351072	0.487083247666449	PRKCG;IRS1;CREB3L2;PLCG2;IGF1;SSTR2
Selenocompound metabolism	1/17	0.601063069154107	0.999995617189958	0	0	1.12583254043768	0.573111145009607	CTH
Hematopoietic cell lineage	5/99	0.601095637032103	0.999995617189958	0	0	0.957853238228779	0.487548473802637	IL5RA;CD38;ITGA6;CD59;HLA-DOB
Primary immunodeficiency	2/38	0.601226839155705	0.999995617189958	0	0	1.00063492063492	0.509106016271233	CD79A;BLNK
Notch signaling pathway	3/59	0.606369365882013	0.999995617189958	0	0	0.964796404739207	0.482654803417544	DLL4;TLE1;HEY2
VEGF signaling pathway	3/59	0.606369365882013	0.999995617189958	0	0	0.964796404739207	0.482654803417544	PRKCG;PLCG2;HSPB1
Ubiquitin mediated proteolysis	7/140	0.608856476008067	0.999995617189958	0	0	0.947620246789222	0.470183306494132	CUL7;FBXW7;UBC;MDM2;SYVN1;RHOBTB2;UBE2J1
Melanogenesis	5/101	0.618898181811737	0.999995617189958	0	0	0.93779847182426	0.449969312375605	PRKCG;FZD3;WNT10A;WNT5B;CREB3L2
Fatty acid biosynthesis	1/18	0.622064937879575	0.999995617189958	0	0	1.05955112777747	0.502980352866848	HSD17B8
Other glycan degradation	1/18	0.622064937879575	0.999995617189958	0	0	1.05955112777747	0.502980352866848	FUCA2
Glycerolipid metabolism	3/61	0.629063008161637	0.999995617189958	0	0	0.931428947108905	0.431739536539648	PLPP5;AKR1A1;MGLL
Hippo signaling pathway	8/163	0.630156809918798	0.999995617189958	0	0	0.929081695711284	0.429037464317368	FZD3;WNT10A;WNT5B;MYC;RASSF6;BMP8B;CSNK1E;BMP6
Cell cycle	6/124	0.640849130383109	0.999995617189958	0	0	0.915351459960463	0.407295898491274	CCNE2;CCNE1;GADD45A;MYC;MDM2;E2F5
Glycosaminoglycan degradation	1/19	0.641962163001061	0.999995617189958	0	0	1.00063431652395	0.443507058684958	NAGLU
Bladder cancer	2/41	0.642804320958257	0.999995617189958	0	0	0.923516483516484	0.408115715751579	MYC;MDM2
Steroid biosynthesis	1/20	0.660812793331844	0.999995617189958	0	0	0.947919274876058	0.39270844918741	TM7SF2
Human papillomavirus infection	16/331	0.672176320219771	0.999995617189958	0	0	0.913550284978856	0.362893774355542	IFNAR2;LAMA5;FZD3;WNT10A;WNT5B;LAMC1;CCNE2;CCNE1;COL4A4;CREB3L2;HEY2;COL4A3;MDM2;ITGA8;COL9A3;ITGA6
Relaxin signaling pathway	6/129	0.678372005346679	0.999995617189958	0	0	0.877908874691041	0.340680844771953	JUN;COL4A4;GNG7;CREB3L2;COL4A3;GNB3
Pantothenate and CoA biosynthesis	1/21	0.678671830210878	0.999995617189958	0	0	0.900475737392959	0.349040227656495	PPCDC
HIF-1 signaling pathway	5/109	0.68519042929453	0.999995617189958	0	0	0.865292777900228	0.327131272700512	PRKCG;INSR;PLCG2;IGF1;PDK1
MAPK signaling pathway	14/294	0.687349531849205	0.999995617189958	0	0	0.899229287090559	0.337132152766751	PRKCG;DUSP5;MEF2C;JUN;HSPA1L;GADD45A;INSR;HSPA6;HSPB1;IGF1;RASGRP3;MYC;HSPA1B;HSPA1A
GABAergic synapse	4/89	0.695164056306455	0.999995617189958	0	0	0.847013920071846	0.307980536892875	PRKCG;GNG7;GNB3;SLC38A5
Terpenoid backbone biosynthesis	1/22	0.695591386951335	0.999995617189958	0	0	0.857550632051108	0.311284772614796	DHDDS
Hypertrophic cardiomyopathy	4/90	0.703515682511252	0.999995617189958	0	0	0.837120539676904	0.29438608712856	MYL2;ITGA8;ITGA6;IGF1
Type II diabetes mellitus	2/46	0.704376039654427	0.999995617189958	0	0	0.818354978354978	0.286786706732937	IRS1;INSR
Amphetamine addiction	3/69	0.71058944952559	0.999995617189958	0	0	0.818181818181818	0.279540362275814	PRKCG;JUN;CREB3L2
Renal cell carcinoma	3/69	0.71058944952559	0.999995617189958	0	0	0.818181818181818	0.279540362275814	JUN;PRCC;GAB1
Renin-angiotensin system	1/23	0.711620840554982	0.999995617189958	0	0	0.818527809013061	0.278471375963627	KLK1
Cushing syndrome	7/155	0.71276972634487	0.999995617189958	0	0	0.850898745635588	0.288111656371293	FZD3;WNT10A;RASD1;WNT5B;CCNE2;CCNE1;CREB3L2
Non-alcoholic fatty liver disease	7/155	0.71276972634487	0.999995617189958	0	0	0.850898745635588	0.288111656371293	ERN1;JUN;XBP1;BCL2L11;IRS1;INSR;EIF2AK3
Carbohydrate digestion and absorption	2/47	0.715573009094806	0.999995617189958	0	0	0.800126984126984	0.267779814727029	SLC2A5;TAS1R3
Pyruvate metabolism	2/47	0.715573009094806	0.999995617189958	0	0	0.800126984126984	0.267779814727029	AKR1A1;ACSS1
Cellular senescence	7/156	0.718987575886482	0.999995617189958	0	0	0.845143058989756	0.278822161712252	CCNE2;CCNE1;GADD45A;MYC;MDM2;E2F5;SLC25A4
Valine, leucine and isoleucine degradation	2/48	0.726411355350697	0.999995617189958	0	0	0.782691511387164	0.250178590694261	MCEE;EHHADH
TGF-beta signaling pathway	4/94	0.735258048465316	0.999995617189958	0	0	0.799745547073791	0.245948751166781	MYC;BMP8B;E2F5;BMP6
Cocaine addiction	2/49	0.736897786194209	0.999995617189958	0	0	0.765997973657548	0.233863842783447	JUN;CREB3L2
Melanoma	3/72	0.737369244952956	0.999995617189958	0	0	0.782484353628715	0.238396770471802	GADD45A;MDM2;IGF1
alpha-Linolenic acid metabolism	1/25	0.741194118376918	0.999995617189958	0	0	0.75023786869648	0.224690779848164	PLA2G2D
Inositol phosphate metabolism	3/73	0.745847943512923	0.999995617189958	0	0	0.771265150483454	0.226160801582135	PIP5KL1;PLCG2;PIP5K1B
Dilated cardiomyopathy	4/96	0.750138882595482	0.999995617189958	0	0	0.782276800531032	0.224902165108446	MYL2;ITGA8;ITGA6;IGF1
Hepatitis B	7/162	0.754361892500813	0.999995617189958	0	0	0.812168544528477	0.228936556671684	PRKCG;JUN;CCNE2;CCNE1;CASP10;MYC;CREB3L2
Maturity onset diabetes of the young	1/26	0.754824269633798	0.999995617189958	0	0	0.720190294957184	0.20256814916132	BHLHA15
Neurotrophin signaling pathway	5/119	0.756434771274336	0.999995617189958	0	0	0.788970994822299	0.220232553874534	JUN;IRS1;MAGED1;PLCG2;GAB1
Circadian entrainment	4/97	0.757334889426325	0.999995617189958	0	0	0.773824181236149	0.215084224649474	PRKCG;RASD1;GNG7;GNB3
Fc gamma R-mediated phagocytosis	4/97	0.757334889426325	0.999995617189958	0	0	0.773824181236149	0.215084224649474	PRKCG;CFL2;PLCG2;PIP5K1B
Apoptosis	6/142	0.763499409992227	0.999995617189958	0	0	0.793442807333258	0.214104929610082	ERN1;JUN;BCL2L11;GADD45A;CASP10;EIF2AK3
Choline metabolism in cancer	4/98	0.764369554269373	0.999995617189958	0	0	0.765551404904986	0.20570664584323	PRKCG;JUN;SLC44A1;PIP5K1B
Inflammatory mediator regulation of TRP channels	4/98	0.764369554269373	0.999995617189958	0	0	0.765551404904986	0.20570664584323	PRKCG;PLCG2;TRPV3;IGF1
Thyroid hormone signaling pathway	5/121	0.769124884399392	0.999995617189958	0	0	0.77528570958074	0.2035139905875	PRKCG;MYC;PLCG2;MDM2;ESR1
Signaling pathways regulating pluripotency of stem cells	6/143	0.769294842286057	0.999995617189958	0	0	0.78760938437705	0.206574955650344	FZD3;WNT10A;WNT5B;MYC;IGF1;TCF3
Chronic myeloid leukemia	3/76	0.769974288130611	0.999995617189958	0	0	0.739451793619494	0.193291335842903	GADD45A;MYC;MDM2
Autoimmune thyroid disease	2/53	0.775467559178002	0.999995617189958	0	0	0.705770308123249	0.17946971719295	HLA-DOB;TSHR
Bacterial invasion of epithelial cells	3/77	0.777589150662589	0.999995617189958	0	0	0.729420554968696	0.183490830696278	CAV2;CAV1;GAB1
AGE-RAGE signaling pathway in diabetic complications	4/100	0.777960413762927	0.999995617189958	0	0	0.749522900763359	0.188189938709608	JUN;COL4A4;COL4A3;PLCG2
Prion disease	12/273	0.777985641454539	0.999995617189958	0	0	0.826127320954907	0.207396959598891	KLC4;HSPA1L;HSPA5;CAV2;CAV1;CREB3L2;HSPA6;EIF2AK3;LAMC1;SLC25A4;HSPA1B;HSPA1A
Butanoate metabolism	1/28	0.779970681561725	0.999995617189958	0	0	0.666772386087324	0.165692236328999	EHHADH
cGMP-PKG signaling pathway	7/167	0.781312813867812	0.999995617189958	0	0	0.786578947368421	0.194111700464416	BORCS8-MEF2B;MEF2C;MEF2B;IRS1;INSR;CREB3L2;SLC25A4
Pancreatic secretion	4/102	0.79092369892942	0.999995617189958	0	0	0.734148621280573	0.172197332292627	PRKCG;PLA2G2D;RAB3D;CD38
Linoleic acid metabolism	1/29	0.79156036952997	0.999995617189958	0	0	0.642925105341851	0.150283184198513	PLA2G2D
Transcriptional misregulation in cancer	8/192	0.797173365372841	0.999995617189958	0	0	0.78144261202732	0.177139834877153	MEF2C;GADD45A;MYC;PRCC;MDM2;IGF1;TCF3;CDK14
Hedgehog signaling pathway	2/56	0.801061476912989	0.999995617189958	0	0	0.666455026455026	0.147831444249732	PTCH2;CSNK1E
Ascorbate and aldarate metabolism	1/30	0.802540133653006	0.999995617189958	0	0	0.62072246464779	0.13654243997185	AKR1A1
beta-Alanine metabolism	1/30	0.802540133653006	0.999995617189958	0	0	0.62072246464779	0.13654243997185	EHHADH
NF-kappa B signaling pathway	4/104	0.803273264824396	0.999995617189958	0	0	0.719389312977099	0.157589651694464	GADD45A;PLCG2;BLNK;LY96
Toll-like receptor signaling pathway	4/104	0.803273264824396	0.999995617189958	0	0	0.719389312977099	0.157589651694464	IFNAR2;JUN;TLR9;LY96
Chemical carcinogenesis	10/239	0.812781246841869	0.999995617189958	0	0	0.78447560536087	0.162616517169362	PRKCG;DLL4;GSTM2;JUN;MYC;CREB3L2;GSTT2B;ESR1;ESR2;HSP90B1
Asthma	1/31	0.81294204313713	0.999995617189958	0	0	0.6	0.124257275777772	HLA-DOB
Galactose metabolism	1/31	0.81294204313713	0.999995617189958	0	0	0.6	0.124257275777772	B4GALT2
Parathyroid hormone synthesis, secretion and action	4/106	0.815024332582711	0.999995617189958	0	0	0.705208801077683	0.144241511342168	PRKCG;MEF2C;CREB3L2;LRP5
Endometrial cancer	2/58	0.81665347316278	0.999995617189958	0	0	0.642585034013605	0.130149442387501	GADD45A;MYC
Long-term depression	2/60	0.831142228472487	0.999995617189958	0	0	0.620361247947455	0.114738508510304	PRKCG;IGF1
Viral myocarditis	2/60	0.831142228472487	0.999995617189958	0	0	0.620361247947455	0.114738508510304	CAV1;HLA-DOB
Insulin secretion	3/86	0.837144877078949	0.999995617189958	0	0	0.650016653841295	0.115545746530363	PRKCG;CREB3L2;KCNN3
Taste transduction	3/86	0.837144877078949	0.999995617189958	0	0	0.650016653841295	0.115545746530363	SCNN1B;GNB3;TAS1R3
Arachidonic acid metabolism	2/61	0.837992357640569	0.999995617189958	0	0	0.609814366424536	0.107782431917097	PLA2G2D;GPX7
Hepatitis C	6/157	0.839581044776664	0.999995617189958	0	0	0.714054170412673	0.124853991016771	IFNAR2;CLDN3;CLDN14;MYC;EIF2AK3;EIF2AK4
Pentose and glucuronate interconversions	1/34	0.840976590752974	0.999995617189958	0	0	0.545368047746735	0.0944530853784847	AKR1A1
Lysine degradation	2/63	0.850942475166777	0.999995617189958	0	0	0.58975800156128	0.095193281021611	EHHADH;EHMT1
Cholinergic synapse	4/113	0.851683809284915	0.999995617189958	0	0	0.659675047272218	0.105904190461034	PRKCG;GNG7;CREB3L2;GNB3
Serotonergic synapse	4/113	0.851683809284915	0.999995617189958	0	0	0.659675047272218	0.105904190461034	PRKCG;GNG7;GNB3;RAPGEF3
Autophagy	5/137	0.853055044814499	0.999995617189958	0	0	0.680732829729964	0.108189687362103	ERN1;IRS1;EIF2AK3;WIPI1;EIF2AK4
Inflammatory bowel disease	2/65	0.86294248460176	0.999995617189958	0	0	0.570975056689342	0.0841658549338307	JUN;HLA-DOB
Morphine addiction	3/91	0.863881024953104	0.999995617189958	0	0	0.612921397001473	0.0896827950374892	PRKCG;GNG7;GNB3
Ras signaling pathway	9/232	0.866192470867249	0.999995617189958	0	0	0.724561350708761	0.104081892070119	PRKCG;PLA2G2D;INSR;GNG7;PLCG2;GAB1;GNB3;IGF1;RASGRP3
Th1 and Th2 cell differentiation	3/92	0.868740411964258	0.999995617189958	0	0	0.606002506399889	0.0852711694415087	DLL4;JUN;HLA-DOB
Allograft rejection	1/38	0.871936845558109	0.999995617189958	0	0	0.486306477743205	0.0666426044856746	HLA-DOB
Acute myeloid leukemia	2/67	0.874050932857863	0.999995617189958	0	0	0.553347985347985	0.0744898406968852	MYC;PIM2
Glycolysis / Gluconeogenesis	2/67	0.874050932857863	0.999995617189958	0	0	0.553347985347985	0.0744898406968852	AKR1A1;ACSS1
Long-term potentiation	2/67	0.874050932857863	0.999995617189958	0	0	0.553347985347985	0.0744898406968852	PRKCG;RAPGEF3
Spinocerebellar ataxia	5/143	0.877191567700779	0.999995617189958	0	0	0.65092811760309	0.0852910300324613	PRKCG;ERN1;XBP1;WIPI1;SLC25A4
IL-17 signaling pathway	3/94	0.878001678984098	0.999995617189958	0	0	0.592620915785835	0.0771039950044772	JUN;IL17RC;HSP90B1
Retinol metabolism	2/68	0.879288572979763	0.999995617189958	0	0	0.544935064935065	0.0701016119711623	DHRS9;PNPLA4
AMPK signaling pathway	4/120	0.88199059229378	0.999995617189958	0	0	0.61963674651224	0.0778101962535211	IRS1;INSR;CREB3L2;IGF1
Kaposi sarcoma-associated herpesvirus infection	7/193	0.886873502176304	0.999995617189958	0	0	0.67569069300818	0.0811186406768318	IFNAR2;JUN;MYC;GNG7;UBC;PLCG2;GNB3
Central carbon metabolism in cancer	2/70	0.889164994253625	0.999995617189958	0	0	0.528851540616247	0.0621254942819252	MYC;PDK1
Epithelial cell signaling in Helicobacter pylori infection	2/70	0.889164994253625	0.999995617189958	0	0	0.528851540616247	0.0621254942819252	JUN;PLCG2
Prolactin signaling pathway	2/70	0.889164994253625	0.999995617189958	0	0	0.528851540616247	0.0621254942819252	ESR1;ESR2
Phosphatidylinositol signaling system	3/97	0.890805850918881	0.999995617189958	0	0	0.573616209966939	0.0663265399415096	PRKCG;PLCG2;PIP5K1B
Ferroptosis	1/41	0.891136056338964	0.999995617189958	0	0	0.44976213130352	0.0518387567944329	SLC39A14
Phospholipase D signaling pathway	5/148	0.894647869680999	0.999995617189958	0	0	0.628001415967032	0.0699123077614749	INSR;PLCG2;GAB1;PIP5K1B;RAPGEF3
Retrograde endocannabinoid signaling	5/148	0.894647869680999	0.999995617189958	0	0	0.628001415967032	0.0699123077614749	PRKCG;CNR1;GNG7;GNB3;MGLL
Human T-cell leukemia virus 1 infection	8/219	0.894973095774884	0.999995617189958	0	0	0.680467033465889	0.0755057255779506	JUN;CCNE2;CCNE1;MYC;CREB3L2;TCF3;HLA-DOB;SLC25A4
Graft-versus-host disease	1/42	0.896873966430501	0.999995617189958	0	0	0.438769116520851	0.0477556010018717	HLA-DOB
Tryptophan metabolism	1/42	0.896873966430501	0.999995617189958	0	0	0.438769116520851	0.0477556010018717	EHHADH
Pathogenic Escherichia coli infection	7/197	0.898543961168839	0.999995617189958	0	0	0.661324603374465	0.0707482724010541	MYO1D;JUN;CLDN3;TMED10;SEC24A;CLDN14;SEC24D
Fat digestion and absorption	1/43	0.902309713511403	0.999995617189958	0	0	0.428299578632595	0.0440281065584033	PLA2G2D
Type I diabetes mellitus	1/43	0.902309713511403	0.999995617189958	0	0	0.428299578632595	0.0440281065584033	HLA-DOB
Viral protein interaction with cytokine and cytokine receptor	3/100	0.902392580616934	0.999995617189958	0	0	0.555787052961583	0.0570824539214242	CCL25;CCR10;CCR2
PPAR signaling pathway	2/74	0.906705310468709	0.999995617189958	0	0	0.499365079365079	0.0489067109918241	EHHADH;UBC
Osteoclast differentiation	4/127	0.906764097631671	0.999995617189958	0	0	0.584155650716813	0.0571730388455117	IFNAR2;JUN;PLCG2;BLNK
Phagosome	5/152	0.907028187763483	0.999995617189958	0	0	0.610782995146483	0.0596012743493652	SEC61A1;C1R;SEC61G;SEC61B;HLA-DOB
Vasopressin-regulated water reabsorption	1/44	0.907459195584193	0.999995617189958	0	0	0.418316995994955	0.0406213735800196	CREB3L2
Lysosome	4/128	0.909899080478361	0.999995617189958	0	0	0.579413937453829	0.0547091830375303	ARSA;NAGLU;FUCA2;ABCB9
Parkinson disease	9/249	0.91193920007752	0.999995617189958	0	0	0.672627037392138	0.0620040771166867	ERN1;KLC4;XBP1;PINK1;HSPA5;UBC;EIF2AK3;SLC25A4;UBE2J1
ABC transporters	1/45	0.912337474509588	0.999995617189958	0	0	0.408788167113571	0.0375044010059745	ABCB9
Protein digestion and absorption	3/103	0.912857505014375	0.999995617189958	0	0	0.539027645376549	0.0491461064224055	COL4A4;COL4A3;COL9A3
Oocyte meiosis	4/129	0.912940003338966	0.999995617189958	0	0	0.574748091603053	0.0523509956198941	CCNE2;CCNE1;IGF1;CPEB4
Gastric acid secretion	2/76	0.914468236798855	0.999995617189958	0	0	0.485817245817246	0.0434381561664462	PRKCG;SSTR2
Metabolism of xenobiotics by cytochrome P450	2/76	0.914468236798855	0.999995617189958	0	0	0.485817245817246	0.0434381561664462	GSTM2;GSTT2B
Pathways of neurodegeneration	19/475	0.915943542141836	0.999995617189958	0	0	0.745885769603098	0.0654891818703706	PRKCG;FZD3;WNT10A;XBP1;WNT5B;HSPA5;DNAH8;EIF2AK3;LRP5;DERL1;GPX7;WIPI1;CSNK1E;UBE2J1;ERN1;KLC4;PINK1;UBC;SLC25A4
C-type lectin receptor signaling pathway	3/104	0.916112471378899	0.999995617189958	0	0	0.533662422486291	0.046757439652075	JUN;PLCG2;MDM2
Arrhythmogenic right ventricular cardiomyopathy	2/77	0.91811833206874	0.999995617189958	0	0	0.479314285714286	0.0409473375418707	ITGA8;ITGA6
Leishmaniasis	2/77	0.91811833206874	0.999995617189958	0	0	0.479314285714286	0.0409473375418707	JUN;HLA-DOB
Natural killer cell mediated cytotoxicity	4/131	0.91874870375259	0.999995617189958	0	0	0.565636833563744	0.047933558182766	IFNAR2;PRKCG;ICAM2;PLCG2
Dopaminergic synapse	4/132	0.921520932369251	0.999995617189958	0	0	0.561187977099237	0.0458657736058597	PRKCG;GNG7;CREB3L2;GNB3
Axon guidance	6/182	0.921530251186461	0.999995617189958	0	0	0.61181122892404	0.0499970143062535	FZD3;WNT5B;DCC;CFL2;PLCG2;RND1
Synaptic vesicle cycle	2/78	0.921621552413385	0.999995617189958	0	0	0.472982456140351	0.0386051134908416	UNC13B;SLC6A9
Th17 cell differentiation	3/107	0.92522324490235	0.999995617189958	0	0	0.51818581799516	0.0402735182360979	JUN;IRF4;HLA-DOB
Coronavirus disease	8/232	0.925700099823082	0.999995617189958	0	0	0.640530925013684	0.0494521664132679	C4B;PRKCG;IFNAR2;C4A;JUN;C1R;PLCG2;CFB
Insulin resistance	3/108	0.928052662135209	0.999995617189958	0	0	0.513223478142449	0.0383207547030852	IRS1;INSR;CREB3L2
Systemic lupus erythematosus	4/135	0.929335237747255	0.999995617189958	0	0	0.54824893654216	0.0401788326075692	C4B;C4A;C1R;HLA-DOB
Ether lipid metabolism	1/49	0.929412946671619	0.999995617189958	0	0	0.374643196955281	0.0274246808646257	PLA2G2D
Sphingolipid metabolism	1/49	0.929412946671619	0.999995617189958	0	0	0.374643196955281	0.0274246808646257	ARSA
Rap1 signaling pathway	7/210	0.929656721456833	0.999995617189958	0	0	0.618544794588352	0.0451165816619849	PRKCG;CNR1;INSR;MAGI3;IGF1;RAPGEF3;RASGRP3
Peroxisome	2/82	0.934270053126039	0.999995617189958	0	0	0.449238095238095	0.0305435841845553	EHHADH;PAOX
TNF signaling pathway	3/112	0.938413375857007	0.999995617189958	0	0	0.494284639805494	0.0314190686083818	JUN;CASP10;CREB3L2
Chemokine signaling pathway	6/192	0.942256232194786	0.999995617189958	0	0	0.578609757601924	0.0344145700797638	CCL25;GNG7;PLCG2;GNB3;CCR10;CCR2
Glutamatergic synapse	3/114	0.943059661086327	0.999995617189958	0	0	0.48532708113261	0.028452654918206	PRKCG;GNG7;GNB3
PD-L1 expression and PD-1 checkpoint pathway in cancer	2/89	0.951880729623426	0.999995617189958	0	0	0.412939244663383	0.0203643202060271	JUN;TLR9
Salmonella infection	8/249	0.953930712624489	0.999995617189958	0	0	0.594807713708844	0.0280536528398528	KLC4;JUN;MYC;MYL2;TLR9;LY96;RHOB;HSP90B1
Alzheimer disease	13/369	0.955034438170591	0.999995617189958	0	0	0.65343729385429	0.0300632634531048	FZD3;WNT10A;XBP1;WNT5B;IRS1;INSR;EIF2AK3;LRP5;WIPI1;CSNK1E;ERN1;KLC4;SLC25A4
Spliceosome	4/150	0.958817598785796	0.999995617189958	0	0	0.491529854648123	0.0206710037255727	HSPA1L;HSPA6;HSPA1B;HSPA1A
Rheumatoid arthritis	2/93	0.95981669436432	0.999995617189958	0	0	0.394704343275772	0.0161879919122327	JUN;HLA-DOB
Salivary secretion	2/93	0.95981669436432	0.999995617189958	0	0	0.394704343275772	0.0161879919122327	PRKCG;CD38
Steroid hormone biosynthesis	1/61	0.963157691269889	0.999995617189958	0	0	0.299524262607041	0.0112435808783053	HSD17B8
Oxytocin signaling pathway	4/154	0.964483312678597	0.999995617189958	0	0	0.478320610687023	0.0172973878565195	PRKCG;MEF2C;JUN;CD38
Cytosolic DNA-sensing pathway	1/63	0.966942664604232	0.999995617189958	0	0	0.289831496884687	0.00974299800891292	ZBP1
MicroRNAs in cancer	10/310	0.967341797239893	0.999995617189958	0	0	0.596545105566219	0.0198073165196323	PRKCG;FZD3;BCL2L11;CCNE2;IRS1;CCNE1;MYC;PLCG2;MDM2;BMF
Aldosterone synthesis and secretion	2/98	0.967982344164614	0.999995617189958	0	0	0.374047619047619	0.0121720449248239	PRKCG;CREB3L2
Glycerophospholipid metabolism	2/98	0.967982344164614	0.999995617189958	0	0	0.374047619047619	0.0121720449248239	PLPP5;PLA2G2D
Purine metabolism	3/129	0.968804851310756	0.999995617189958	0	0	0.427209587362114	0.0135391600817784	AMPD1;ADA2;FHIT
Human immunodeficiency virus 1 infection	6/212	0.969670149373928	0.999995617189958	0	0	0.521877146410737	0.0160734599321563	PRKCG;JUN;CFL2;GNG7;PLCG2;GNB3
Cortisol synthesis and secretion	1/65	0.970339095443783	0.999995617189958	0	0	0.280744529019981	0.0084531295147415	CREB3L2
Necroptosis	4/159	0.970546682333919	0.999995617189958	0	0	0.462767791184437	0.013834802321038	IFNAR2;ZBP1;CHMP4C;SLC25A4
Progesterone-mediated oocyte maturation	2/100	0.970779390707284	0.999995617189958	0	0	0.366375121477162	0.0108652332571045	IGF1;CPEB4
Amyotrophic lateral sclerosis	12/364	0.971972284438145	0.999995617189958	0	0	0.609571678321678	0.0173288968933513	ERN1;KLC4;XBP1;SEC13;PINK1;HSPA5;DNAH8;EIF2AK3;DERL1;GPX7;WIPI1;ANG
Chagas disease	2/102	0.973340021290443	0.999995617189958	0	0	0.359009523809524	0.00970108398944245	JUN;TLR9
cAMP signaling pathway	6/216	0.973453633548493	0.999995617189958	0	0	0.511827369571155	0.013770758327704	JUN;GIPR;CREB3L2;SSTR2;RAPGEF3;TSHR
Fc epsilon RI signaling pathway	1/68	0.974791270496891	0.999995617189958	0	0	0.268131275118224	0.00684590423999474	PLCG2
Cytokine-cytokine receptor interaction	9/295	0.97522460561994	0.999995617189958	0	0	0.56305439526916	0.0141256101234305	CCL25;IFNAR2;BMP8B;IL5RA;TNFRSF17;IL17RC;CCR10;BMP6;CCR2
Adipocytokine signaling pathway	1/69	0.976121650302292	0.999995617189958	0	0	0.264174175854928	0.00638457697138852	IRS1
Shigellosis	7/246	0.976620680045168	0.999995617189958	0	0	0.52436587856099	0.0124048984330132	JUN;MYL2;UBC;TIFA;PLCG2;MDM2;WIPI1
RIG-I-like receptor signaling pathway	1/70	0.977381875899854	0.999995617189958	0	0	0.260331775121003	0.00595582804572501	CASP10
Adherens junction	1/71	0.978575643232681	0.999995617189958	0	0	0.25659915726519	0.00555721666099609	INSR
Glucagon signaling pathway	2/107	0.978828692233834	0.999995617189958	0	0	0.341823129251701	0.00731454809005276	SIK1B;CREB3L2
Drug metabolism	2/108	0.9797867190924	0.999995617189958	0	0	0.338580413297394	0.00691393547996771	GSTM2;GSTT2B
Tight junction	4/169	0.979882555276953	0.999995617189958	0	0	0.434489937543373	0.00882994611028615	JUN;CLDN3;CLDN14;MYL2
Human cytomegalovirus infection	6/225	0.980427944466677	0.999995617189958	0	0	0.490557636396972	0.00969642336764366	PRKCG;MYC;GNG7;CREB3L2;MDM2;GNB3
Pancreatic cancer	1/76	0.983663907666947	0.999995617189958	0	0	0.239429115128449	0.00394363636218702	GADD45A
Viral carcinogenesis	5/203	0.983790756203961	0.999995617189958	0	0	0.452230036757257	0.00739036617810672	JUN;CCNE2;CCNE1;CREB3L2;MDM2
Thermogenesis	6/232	0.984628951574615	0.999995617189958	0	0	0.475185705341884	0.00736082030322038	NDUFAF6;CNR1;COX18;CREB3L2;BMP8B;MGLL
RNA degradation	1/79	0.986117097438655	0.999995617189958	0	0	0.23018370782405	0.00321800767762324	BTG2
Adrenergic signaling in cardiomyocytes	3/150	0.987013406021653	0.999995617189958	0	0	0.365771093947589	0.00478123429724198	MYL2;CREB3L2;RAPGEF3
Calcium signaling pathway	6/240	0.988391425657533	0.999995617189958	0	0	0.458743932931313	0.00535651430177644	PRKCG;P2RX1;MST1;PLCG2;CD38;SLC25A4
Platelet activation	2/124	0.990444055938864	0.999995617189958	0	0	0.293926619828259	0.00282225256061137	P2RX1;PLCG2
Regulation of actin cytoskeleton	5/218	0.99071893299816	0.999995617189958	0	0	0.420046544789271	0.00391668387472911	MYL2;CFL2;ITGA8;PIP5K1B;ITGA6
Cardiac muscle contraction	1/87	0.991005204189835	0.999995617189958	0	0	0.208682760604518	0.00188555166711788	MYL2
Gap junction	1/88	0.991480261002535	0.999995617189958	0	0	0.206273171691985	0.00176492264658489	PRKCG
JAK-STAT signaling pathway	3/162	0.99224352352387	0.999995617189958	0	0	0.337949889382521	0.00263151927051013	IFNAR2;MYC;IL5RA
GnRH signaling pathway	1/93	0.993504840649125	0.999995617189958	0	0	0.195010962644273	0.0012707586495411	JUN
Vascular smooth muscle contraction	2/133	0.993767833098467	0.999995617189958	0	0	0.273602326426754	0.00171047088649191	PRKCG;PLA2G2D
Diabetic cardiomyopathy	4/203	0.994807483044981	0.999995617189958	0	0	0.359603360313015	0.00187211124751935	PRKCG;IRS1;INSR;SLC25A4
Insulin signaling pathway	2/137	0.994852351274125	0.999995617189958	0	0	0.265439153439153	0.00136991647725093	IRS1;INSR
Yersinia infection	2/137	0.994852351274125	0.999995617189958	0	0	0.265439153439153	0.00136991647725093	JUN;PIP5K1B
Influenza A	3/172	0.994986426555486	0.999995617189958	0	0	0.317783631635652	0.00159723886794183	IFNAR2;HLA-DOB;SLC25A4
T cell receptor signaling pathway	1/104	0.996424811165481	0.999995617189958	0	0	0.174082935345903	0.000623494587486916	JUN
Tuberculosis	3/180	0.996478056420774	0.999995617189958	0	0	0.303291270136207	0.00107006019535414	CASP10;TLR9;HLA-DOB
NOD-like receptor signaling pathway	3/181	0.996630931015876	0.999995617189958	0	0	0.301571319930164	0.00101772994595667	IFNAR2;JUN;NLRP7
Huntington disease	7/306	0.997022609555125	0.999995617189958	0	0	0.417797762877854	0.0012458026091694	ERN1;KLC4;DNAH8;CREB3L2;GPX7;WIPI1;SLC25A4
Ribosome biogenesis in eukaryotes	1/108	0.997122581429499	0.999995617189958	0	0	0.167539592911068	0.000482776444467174	GNL3
Alcoholism	3/186	0.997303342559715	0.999995617189958	0	0	0.293253527950116	0.000791872492981772	GNG7;CREB3L2;GNB3
Neutrophil extracellular trap formation	3/189	0.99764187356118	0.999995617189958	0	0	0.288477505458347	0.000681069772923414	PRKCG;PLCG2;SLC25A4
Sphingolipid signaling pathway	1/119	0.998416143950072	0.999995617189958	0	0	0.151832798464739	0.000240671941633622	PRKCG
RNA transport	2/186	0.999526504885715	0.999995617189958	0	0	0.194244306418219	9.19955114985063e-05	SEC13;GEMIN7
Neuroactive ligand-receptor interaction	6/341	0.999756353987949	0.999995617189958	0	0	0.318706657915014	7.766106750415e-05	GIPR;CNR1;P2RX1;KISS1R;SSTR2;TSHR
Herpes simplex virus 1 infection	9/498	0.99997617853604	0.999995617189958	0	0	0.325729814303949	7.75945345326363e-06	IFNAR2;ZNF275;EIF2AK3;TLR9;ZNF547;EIF2AK4;HLA-DOB;ZNF552;ZNF860
Olfactory transduction	1/440	0.999995617189958	0.999995617189958	0	0	0.0401158241743951	1.75820422346615e-07	GNG7
